docetaxel anhydrous has been researched along with Esophageal Stenosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Inaki, N; Kinoshita, J; Moriyama, H; Nakamura, K; Okamoto, K; Saito, H; Shimada, M; Tsuji, T; Yamaguchi, T | 1 |
Doki, Y; Kobayashi, T; Makino, T; Mori, M; Tanaka, K; Yamasaki, M | 1 |
Cha, J; Kim, SK; Koom, WS; Lee, CG; Lee, IJ; Lee, JY; Suh, YG | 1 |
Busse, PM; Goguen, L; Guadagnolo, BA; Haddad, RI; Norris, CM; Posner, MR; Sullivan, CA; Tishler, R; Weeks, L; Wirth, LJ | 1 |
1 trial(s) available for docetaxel anhydrous and Esophageal Stenosis
Article | Year |
---|---|
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Dose Fractionation, Radiation; Esophageal Stenosis; Female; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Taxoids | 2005 |
3 other study(ies) available for docetaxel anhydrous and Esophageal Stenosis
Article | Year |
---|---|
Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis.
Topics: Cisplatin; Constriction, Pathologic; Deglutition Disorders; Docetaxel; Esophageal Stenosis; Fluorouracil; Humans | 2023 |
Successful Stenting Followed by Surgery for Perforated Esophageal Cancer Due to Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Contrast Media; Deglutition Disorders; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Perforation; Esophageal Stenosis; Esophagectomy; Fluorouracil; Follow-Up Studies; Humans; Male; Neoadjuvant Therapy; Risk Assessment; Stents; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Radiation; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Stenosis; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Platinum Compounds; Prognosis; Radiation Pneumonitis; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Taxoids; Treatment Failure; Treatment Outcome | 2014 |